Flanagan W. Michael
- SEC CIK
- 0001841990
In the past year, 2 open-market sale filings worth $644.8K and no purchases.
Current role at each company
- RNA Atrium Therapeutics, Inc.Directoras of Sep 22, 2026
- Avidity Biosciences, Inc.Chief Scientific Officeras of Feb 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $644.8K
- 2 filings
- Net
- −$644.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Flanagan W. Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Avidity Biosciences, Inc.
Chief Scientific Officer14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 (view filing) | Jan 21 | 2 days | Flanagan W. MichaelChief Scientific Officer | SSale | −6.53K | $72.45 | −$473.4K | −7.1%85.1K after | 2 lots10b5-1 |
| Jan 9, 2026 (view filing) | Jan 7 | 2 days | Flanagan W. MichaelChief Scientific Officer | SSale | −2.37K | $72.23 | −$171.4K | −2.5%91.6K after | 10b5-1 |
| Sep 12, 2025 (view filing) | Sep 11 | 1 day | Flanagan W. MichaelChief Scientific Officer | SSale | −20.0K | $38.94 | −$778.8K | −20.0%80.2K after | 10b5-1 |
| Jun 12, 2025 (view filing) | Jun 11 | 1 day | Flanagan W. MichaelChief Scientific Officer | SSale | −20.0K | $32.88 | −$657.6K | −20.0%80.2K after | 10b5-1 |
| Mar 21, 2025 (view filing) | Mar 20 | 1 day | Flanagan W. MichaelChief Scientific Officer | SSale | −11.8K | $31.06 | −$365.9K | −12.8%80.2K after | 10b5-1 |
| Mar 12, 2025 (view filing) | Mar 11 | 1 day | Flanagan W. MichaelChief Scientific Officer | SSale | −20.0K | $30.13 | −$602.6K | −17.9%92.0K after | 10b5-1 |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Flanagan W. MichaelChief Scientific Officer | SSale | −5.67K | $28.60 | −$162.2K | −5.8%92.0K after | 2 lots10b5-1 |
| Dec 19, 2024 (view filing) | Dec 18 | 1 day | Flanagan W. MichaelCSTO | SSale | −12.7K | $32.66 | −$416.2K | −14.9%72.6K after | 10b5-1 |
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Flanagan W. MichaelCSTO | SSale | −24.0K | $35.77 | −$858.5K | −21.9%85.4K after | 10b5-1 |
| Oct 3, 2024 (view filing) | Oct 1 | 2 days | Flanagan W. MichaelCSTO | SSale | −62.5K | $47.62 | −$2.98M | −42.3%85.4K after | 10b5-1 |